1 |
Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview. J Am Acad Dermatol 2011;65:473-491
DOI
|
2 |
Sun X, Xu A, Wei X, Ouyang J, Lu L, Chen M, et al. Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol 2006;45:1176-1181
DOI
|
3 |
Sehgal VN, Srivastava G. Vitiligo: auto-immunity and immune responses. Int J Dermatol 2006;45:583-590
DOI
|
4 |
Kim KT, Ahn SK, Lee SH, Lee WS. A case of vitiligo associated with systemic lupus erythematosus. Korean J Dermatol 1994;32:1077-1081
|
5 |
Jeon SY, Hong JW, Song KH, Kim KH. Vitiligo developed in a patient with discoid lupus erythematosus. Korean J Dermatol 2012;50:830-833
|
6 |
Dwivedi M, Kemp EH, Laddha NC, Mansuri MS, Weetman AP, Begum R. Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmunity Reviews 2015;14:49-56
DOI
|
7 |
Lee H, Lee M, Lee DY, Kang HY, Kim KH, Choi GS, et al. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 2015;56:719-725
DOI
|
8 |
Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol 2013;149(2):159-164
DOI
|
9 |
Nath SK, Kelly JA, Namjou B, Lam T, Bruner GR, Scofield RH, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;69:1401-1406
DOI
|
10 |
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz R. Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res 2003;16:208-214
DOI
|
11 |
Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004;74:188-191
DOI
|